Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Strong short-term momentum backed by a recent operating catalyst: on 2026-05-06 the company raised full-year 2026 guidance for revenue, medical margin, and adjusted EBITDA, while the stock gained about 55% over 21 trading days and continued closing near the top of its range.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Modest Profitability ⢠Negative Cash Flow ⢠Elevated Liabilities AGL returned to modest quarterly profitability, but weak cash flow, thin margins, and liabilities six times equity keep its financial profile risky.
Price Behavior
Key Price Behavior Insights: ⢠Volatile rebound ⢠Repeated resistance ⢠Support holds Support Level: $92.70â$93.60; secondary support near $86.30 Resistance Level: $96.80â$99.10 AGL remains volatile but range-bound over the last month, holding above its 21-day average while facing resistance at $96.80â$99.10; a break above $99.10 would strengthen momentum, whereas a drop below $92.70â$93.60 risks a retest of $86.30.
Sentiment & News
Key News Insights: ⢠Earnings Beat ⢠Guidance Raised ⢠Legal Investigations Agilon Health delivered a major earnings beat, raised 2026 guidance, and strengthened operations and liquidity, though shareholder investigations remain a risk.
AI Summary
AGL Energy is shifting from a coal-recovery story to a battery-and-renewables flexibility platform, with strong free cash flow and battery returns supporting dividends, but investors should require evidence that replacement capacity scales before coal earnings decline and capital intensity weighs on returns.
Description
agilon health, inc. provides healthcare services for senior patients through primary care physicians in communities across the United States. As of December 31, 2021, the company served about 238,000 senior members, including 186,300 Medicare Advantage members and 51,700 Medicare fee-for-service beneficiaries. Founded in 2016 and based in Austin, Texas, the company adopted its current name in March 2021.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jun 10 | Jun 17 | AGL | Agilon Health, Inc. | Strong short-term momentum backed by a recent operating catalyst: on 2026-05-06 the company raised full-year 2026 guidance for revenue, medical margin, and adjusted EBITDA, while the stock gained about 55% over 21 trading days and continued closing near the top of its range. | Closed | +2.9% |
| May 21 | May 28 | AGL | Agilon Health, Inc. | High-risk but clear short-term momentum catalyst: 2026-05-06 Q1 update beat estimates and raised full-year 2026 guidance for revenue, medical margin, and adjusted EBITDA. Stock surged sharply after earnings and is up about 206% over 21 trading days. | Closed | +12.2% |